Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV‑2 Main Protease by Julia M. Flynn (16475720)

“…Drugs that target the main protease (M^pro) of SARS-CoV-2 are effective therapeutics that have entered clinical use. …”

Rates of non-confirmed pulmonary tuberculosis among people with TB/HIV coinfection in municipalities in the state of São Paulo, according to the implementation period of rapid mole... by Mariana Gaspar Botelho Funari de Faria (18784311)

S1 Data - by Mariana Gaspar Botelho Funari de Faria (18784311)

Sociodemographic profile, comorbidities and use of psychoactive substances of cases of pulmonary tuberculosis and HIV coinfection in the pre- and post-Xpert implementation periods... by Mariana Gaspar Botelho Funari de Faria (18784311)

S1 Data - by Mariana Gaspar Botelho Funari de Faria (18784311)

Xpert coverage or at least one of the three available test for pulmonary tuberculosis in people with TB/HIV coinfection from 2010 to 2020 reported in 21 municipalities in the state... by Mariana Gaspar Botelho Funari de Faria (18784311)

Breaks and temporal trend of non-confirmed pulmonary tuberculosis among people with TB/HIV coinfection reported in four municipalities in the state of São Paulo between 2010 and 20... by Mariana Gaspar Botelho Funari de Faria (18784311)

Breaks and temporal trend of non-confirmed pulmonary tuberculosis among people with TB/HIV coinfection reported in four municipalities in the state of São Paulo between 2010 and 20... by Mariana Gaspar Botelho Funari de Faria (18784311)

Temporal trend of non-confirmed pulmonary tuberculosis and the coverage of rapid molecular test (Xpert) among patients with TB/HIV coinfection in 21 municipalities in the state of... by Mariana Gaspar Botelho Funari de Faria (18784311)

Effect of deferiprone in HIV-infected primary cells: Apoptotic DNA fragmentation, deoxyhypusyl-eIF5A accumulation, and DOHH activity. by Deepti Saxena (462177)

Survival curves for HCC patients with the <i>DICER</i> rs3742330 AA genotype (reference) and the GG genotype. by Mi Na Kim (3111618)

Survival curves for HCC patients with the <i>RAN</i> rs14035 CC genotype (reference) and the CT genotype. by Mi Na Kim (3111618)

Effect of different polyunsaturated fatty acids (PUFAs) in the inhibition of HCoV-229Eviral replication in MRC5 cells using antibody-based assay demonstrates significant inhibition... by Amanda Watson (4447267)

Mitochondrial dysfunction in sIBM patients. by Yoshitsugu Oikawa (9721356)

Gaussian model fitted of the number of dogs detections of SARS-CoV-2, depending on the cycle threshold (Ct) values of RT-qPCR tests for SARS-CoV-2. by Víctor M. Vidal-Martínez (18707335)

DataSheet_1_Bortezomib Inhibits Multiple Myeloma Cells by Transactivating ATF3 to Trigger miR-135a-5p- Dependent Apoptosis.docx by Xiaolan Lai (11464909)

“…This was accompanied by low levels of Noxa, CHOP, and DR5, and a decrease in mitochondrial membrane potential. …”

AdV-ZFP-VEGF administration reduces apoptosis after SCI. by Sarah A. Figley (389639)

“…Values are mean ± SEM, n = 4/sham and injured control groups, n = 5/AdV-eGFP and AdV-ZFP-VEGF groups. …”

Novel model for the manipulation of host responses by <i>Mycobacterium avium</i> subsp. <i>paratuberculosis</i> (MAP) for its survival during subclinical stages of Johne’s disease.... by Hyun-Eui Park (4047733)

“…<p>MAP can manipulate host responses to enhance its survival. Upregulation of PIP5K1C and downregulation of IL-17A, IL-17F, and IL-26 induces a loss of granuloma integrity, which can result in fecal shedding and dissemination of MAP. …”

Scotopic and photopic light responses are decreased in WT and miR-150^-/- mice fed with HFD. by Liheng Shi (144105)

Oct-2 knockdown decreases EBNA1 protein expression in cells with type I and type III latency. by Amanda R. Robinson (184305)